Apigenin alleviates STZ-induced diabetic cardiomyopathy

Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes

(2016) Eberhard Standl et al.   CIRCULATION RESEARCH

Vascular Complications of Diabetes

(2016) Joshua A. Beckman et al.   CIRCULATION RESEARCH

Molecular mechanisms of flavonoids in melanin synthesis and the potential for the prevention and treatment of melanoma

(2016) Feng Liu-Smith et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Hyperglycemia and hyperlipidemia blunts the Insulin-Inpp5f negative feedback loop in the diabetic heart

(2016) Danna Bai et al.   Scientific Reports

Inhibition of the STAT3 signaling pathway contributes to apigenin-mediated anti-metastatic effect in melanoma

(2016) Hui-Hui Cao et al.   Scientific Reports

Myocardial Metabolism in Diabetic Cardiomyopathy: Potential Therapeutic Targets

(2015) Miranda M. Sung et al.   ANTIOXIDANTS & REDOX SIGNALING

Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes

(2015) Petar M. Seferović et al.   EUROPEAN HEART JOURNAL

Oleanolic acid alleviated pressure overload-induced cardiac remodeling

(2015) Hai-Han Liao et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Dietary apigenin reduces LPS-induced expression of miR-155 restoring immune balance during inflammation

(2015) Daniel Arango et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy

(2015) Guanghong Jia et al.   Nature Reviews Endocrinology

Efficacy of flavonoids in the management of high blood pressure

(2015) Jaime L. Clark et al.   NUTRITION REVIEWS

MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism

(2015) Surendra K. Shukla et al.   Oncotarget

Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation

(2013) Yang Bai et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Cardioprotective effects of different flavonoids against myocardial ischaemia/reperfusion injury in Langendorff-perfused rat hearts

(2013) Lara Testai et al.   JOURNAL OF PHARMACY AND PHARMACOLOGY

Molecular basis for the action of a dietary flavonoid revealed by the comprehensive identification of apigenin human targets

(2013) D. Arango et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The flavonoid apigenin improves glucose tolerance through inhibition of microRNA maturation in miRNA103 transgenic mice

(2013) Motoko Ohno et al.   Scientific Reports

Na+/Ca2+ exchanger-1 protects against systolic failure in the Akitains2 model of diabetic cardiomyopathy via a CXCR4/NF-κB pathway

(2012) Thomas J. LaRocca et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Protection by chrysin, apigenin, and luteolin against oxidative stress is mediated by the Nrf2-dependent up-regulation of heme oxygenase 1 and glutamate cysteine ligase in rat primary hepatocytes

(2012) Chin-Shiu Huang et al.   ARCHIVES OF TOXICOLOGY

Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome

(2012) C. Escande et al.   DIABETES

Apigenin and its impact on gastrointestinal cancers

(2012) Émilie C. Lefort et al.   MOLECULAR NUTRITION & FOOD RESEARCH

Insulin Resistance and Heart Failure

(2012) Annayya R. Aroor et al.   Heart Failure Clinics

Cannabidiol Attenuates Cardiac Dysfunction, Oxidative Stress, Fibrosis, and Inflammatory and Cell Death Signaling Pathways in Diabetic Cardiomyopathy

(2010) Mohanraj Rajesh et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Apigenin: A Promising Molecule for Cancer Prevention

(2010) Sanjeev Shukla et al.   PHARMACEUTICAL RESEARCH

Insulin Resistance: A Potential New Target for Therapy in Patients with Heart Failure

(2008) Aaron K.F. Wong et al.   Cardiovascular Therapeutics

Cardiomyopathy in Type 2 Diabetes

(2008) Justin Saunders et al.   HERZ